Proteases - Factor Xa - HCV polymerase
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
- A3690 Otamixaban中文名: 奥米沙班Target: Factor XaSummary: 因子Xa抑制剂
- A3381 Edoxaban中文名: 依度沙班Target: Factor XaSummary: 因子Xa抑制剂
- A3126 5-R-Rivaroxaban中文名: 5-R-利伐沙班Target: Factor XaSummary: 因子Xa(FXa)抑制剂
- A4032 VX-222 (VCH-222, Lomibuvir)Target: HCV polymeraseSummary: HCV RNA聚合酶抑制剂
- A8189 PSI-62063 CitationTarget: HCV polymeraseSummary: HCV RNA聚合酶抑制剂